Research

Digital measurement of respiratory disease at home

البحث العلمي — أمراض الرئة والصحة الرقمية

One question runs through this work: can data generated by patients at home reveal that lung disease is worsening earlier and more reliably than clinic visits can?

How the work connects

  1. 01Digital technologies
  2. 02Home and remote physiological measurement
  3. 03Patient-generated data
  4. 04Respiratory disease monitoring
  5. 05ILD and COPD progression or exacerbation research
  6. 06Clinically useful digital monitoring systems

Research themes

Interstitial lung disease

Classification, epidemiology and progression of ILD, including drug-induced ILD in Saudi Arabia and autoimmune-related disease.

Digital health

How digital technologies change respiratory care pathways, and what evidence is needed before they are trusted clinically.

Remote patient monitoring

Designing and evaluating monitoring programmes that operate outside the hospital, including whole-service evaluation.

Home monitoring

Home spirometry, symptoms, physiology and patient-reported outcomes as a way to detect progression and exacerbations earlier.

Wearables & digital biomarkers

Wearable and sensor-derived measures in COPD and ILD, and the machine-learning approaches used to detect exacerbations passively.

Tobacco control

Smoking and nicotine cessation for Arabic-speaking populations, delivered through AQla and related public-health work.

Research journey

Each stage answers a question raised by the one before it.

  1. Evidence synthesis

    Home monitoring of physiology and symptoms to detect ILD exacerbations and progression — systematic review

    Established what home-measured physiology and symptoms can actually detect in ILD.

  2. Clinical implementation

    Telehealth for ILD — international clinician survey

    Mapped how clinicians use and trust remote care, and where it breaks down.

  3. Research infrastructure

    RALPMH — Remote Assessment of Lung Disease and Impact on Physical and Mental Health

    Prospective platform using RADAR-base, the RADAR app, home spirometry, wearables and patient-reported outcomes.

  4. Service evaluation

    Evaluating a remote monitoring programme for respiratory diseases

    Tested whether remote monitoring works as a real service, not only as a study.

  5. Prospective ILD monitoring

    Home monitoring to detect progression of ILD

    Prospective cohort linking home-generated data to disease progression.

  6. Patient experience

    Supporting self-management for patients with ILD — utility and acceptability of digital devices

    Centres the people generating the data: what they will actually use, and why.

  7. Field synthesis

    The role of digital health in respiratory diseases management

    Positions home monitoring within the wider digital respiratory field.

  8. Specialised application

    Remote patient monitoring in autoimmune-related ILD

    Extends the programme to a group where progression is hard to catch early.

Doctoral research

PhD in Respiratory Medicine, University College London (2021–2024). Thesis: Home Monitoring in Interstitial Lung Disease. The thesis brought together home spirometry, symptom reporting, wearable physiology and patient-reported outcomes collected through the RADAR-base platform and RADAR app.

UCL profile and institutional record